Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure

Pál Pacher, Lucas Liaudet, Jon G. Mabley, Katalin Komjáti, Csaba Szabó

    Research output: Contribution to journalArticlepeer-review

    99 Scopus citations

    Fingerprint

    Dive into the research topics of 'Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure'. Together they form a unique fingerprint.

    Medicine & Life Sciences